Results 211 to 220 of about 228,751 (254)
Some of the next articles are maybe not open access.
Heart Lung and Circulation, 2019
Defibrillator technology for sudden cardiac death (SCD) prevention now includes the transvenous implantable cardiac defibrillator (ICD), subcutaneous ICD (S-ICD) and wearable cardioverter defibrillator (WCD). ICD use improves survival in patients who survived previous sudden cardiac arrest (SCA) due to ventricular tachycardia (VT)/ventricular ...
David Chieng
exaly +3 more sources
Defibrillator technology for sudden cardiac death (SCD) prevention now includes the transvenous implantable cardiac defibrillator (ICD), subcutaneous ICD (S-ICD) and wearable cardioverter defibrillator (WCD). ICD use improves survival in patients who survived previous sudden cardiac arrest (SCA) due to ventricular tachycardia (VT)/ventricular ...
David Chieng
exaly +3 more sources
Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management
The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) eliminates the need for transvenous leads, and therefore has the potential to improve lead-longevity and reduce lead-related complications. The S-ICD has a morphology-based sensing algorithm of which inappropriate shocks have been reported.We analyzed the incidence, predictors and
Olde Nordkamp, Louise R A +11 more
openaire +4 more sources
Subcutaneous ICD sports safety registry (SISS registry)
Exercise has a positive impact on physical function and quality of life. However, individuals with an implantable cardioverter-defibrillator (ICD) may experience adverse events during sports activities. To date, scientific data on the safety of sports participation in patients with subcutaneous ICDs (S-ICDs) are lacking.
Nesti, Martina +13 more
openaire +3 more sources
Transvenous or Subcutaneous ICD — Similar but Different
New England Journal of Medicine, 2020The results of the long-awaited Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy (PRAETORIAN) trial — a randomized, controlled trial ...
Mark S, Link, Jose A, Joglar
openaire +2 more sources
Recent developments in the subcutaneous ICD
Trends in Cardiovascular Medicine, 2016The subcutaneous implantable cardioverter-defibrillator (ICD) was developed as a simple device to reduce the morbidity of ICD therapy while providing a comparable reduction in sudden death from ventricular fibrillation. This review highlights the differences compared to the traditional ICD.
Mark E, Willcox +2 more
openaire +2 more sources
A subcutaneous ICD—preliminary results
Nature Reviews Cardiology, 2010N ...
Paolo Spirito, Giuseppe Boriani
openaire +3 more sources
Implantation of a Fully Subcutaneous ICD in Children
Pacing and Clinical Electrophysiology, 2010The subcutaneous implantable cardioverter defibrillator (S‐ICD) from Cameron Health (San Clemente, CA, USA) does not require a lead to be placed on or in the heart. Such a device, being subcutaneous, has potential benefits in children who require ICDs where problems largely relate to transvenous or epicardial leads and inappropriate shocks.
Karen A, McLeod, Andrew, McLean
openaire +2 more sources
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) does not require the insertion of any leads into the cardiovascular system. Objective: The aims of the study were to describe current practice and to measure outcomes associated ...
Federico Migliore
exaly +2 more sources

